Pros and Cons of Ampio Pharmaceuticals Inc. in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ampio Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ampio Pharmaceuticals Inc. | - | - | - | - | - | - | - |
| Protara Therapeutics Inc. | -1.780% | -15.323% | -11.017% | 65.094% | 17.713% | 45.028% | -63.287% |
| India Globalization Capital | -0.870% | 3.636% | 0.000% | -10.236% | -4.202% | -29.499% | -85.639% |
| Gensight Biologics SA | -10.120% | -2.317% | 5.673% | -66.203% | -29.365% | -97.419% | -99.041% |
Comments
Ampio Pharmaceuticals, Inc. (NYSE: AMPE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for AMPE provided by MarketBeat
Ampio Pharmaceuticals, Inc. (NYSE: AMPE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for AMPE provided by MarketBeat
Ampio Pharmaceuticals, Inc. (NYSE: AMPE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for AMPE provided by MarketBeat